<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>Repository Collection:</title>
  <link rel="alternate" href="http://schca-ir.schmc.ac.kr/handle/2022.oak/82" />
  <subtitle />
  <id>http://schca-ir.schmc.ac.kr/handle/2022.oak/82</id>
  <updated>2026-10-23T07:06:49Z</updated>
  <dc:date>2026-10-23T07:06:49Z</dc:date>
  <entry>
    <title>Standard of care therapy with or without stereotactic ablative radiation therapy for recurrent ovarian cancer (SABR-ROC): a prospective randomized phase III trial (KGOG 3064/KROG 2204)</title>
    <link rel="alternate" href="http://schca-ir.schmc.ac.kr/handle/2022.oak/4714" />
    <author>
      <name>Chan Woo Wee</name>
    </author>
    <author>
      <name>So-Jin Shin</name>
    </author>
    <author>
      <name>Jae Hong No</name>
    </author>
    <author>
      <name>Keun Ho Lee</name>
    </author>
    <author>
      <name>Myong Cheol Lim</name>
    </author>
    <author>
      <name>JaeWeon Kim</name>
    </author>
    <author>
      <name>Won Kyung Cho</name>
    </author>
    <author>
      <name>Min Sun Kyung</name>
    </author>
    <author>
      <name>Jae Yun Song</name>
    </author>
    <author>
      <name>Kyung Jin Min</name>
    </author>
    <author>
      <name>Eun Ji Lee</name>
    </author>
    <author>
      <name>Seob Jeon</name>
    </author>
    <author>
      <name>Jae-Hoon Kim</name>
    </author>
    <author>
      <name>Young Seok Kim</name>
    </author>
    <author>
      <name>Ju-Won Roh</name>
    </author>
    <author>
      <name>Jong Hoon Lee</name>
    </author>
    <author>
      <name>Youngmin Choi</name>
    </author>
    <author>
      <name>Hyun Ju Kim</name>
    </author>
    <author>
      <name>Yun Hwan Kim</name>
    </author>
    <author>
      <name>Yong Bae Kim</name>
    </author>
    <id>http://schca-ir.schmc.ac.kr/handle/2022.oak/4714</id>
    <updated>2024-09-27T07:02:09Z</updated>
    <published>2022-12-31T15:00:00Z</published>
    <summary type="text">Title: Standard of care therapy with or without stereotactic ablative radiation therapy for recurrent ovarian cancer (SABR-ROC): a prospective randomized phase III trial (KGOG 3064/KROG 2204)
All Author(s): Chan Woo Wee; So-Jin Shin; Jae Hong No; Keun Ho Lee; Myong Cheol Lim; JaeWeon Kim; Won Kyung Cho; Min Sun Kyung; Jae Yun Song; Kyung Jin Min; Eun Ji Lee; Seob Jeon; Jae-Hoon Kim; Young Seok Kim; Ju-Won Roh; Jong Hoon Lee; Youngmin Choi; Hyun Ju Kim; Yun Hwan Kim; Yong Bae Kim</summary>
    <dc:date>2022-12-31T15:00:00Z</dc:date>
  </entry>
  <entry>
    <title>A randomized, multicenter, open-label phase III trial of hyperthermic intraperitoneal chemotherapy in platinum-resistant recurrent ovarian cancer</title>
    <link rel="alternate" href="http://schca-ir.schmc.ac.kr/handle/2022.oak/4713" />
    <author>
      <name>Ji Hyun Kim</name>
    </author>
    <author>
      <name>Eun-Young Park</name>
    </author>
    <author>
      <name>Dae Hoon Jeong</name>
    </author>
    <author>
      <name>Yoo Young Lee</name>
    </author>
    <author>
      <name>Chel Hun Choi</name>
    </author>
    <author>
      <name>Tae-Joong Kim</name>
    </author>
    <author>
      <name>Hyun Hoon Chung</name>
    </author>
    <author>
      <name>Taek Sang Lee</name>
    </author>
    <author>
      <name>Shin Wha Lee</name>
    </author>
    <author>
      <name>Jeong-Yeol Park</name>
    </author>
    <author>
      <name>Sung Jong Lee</name>
    </author>
    <author>
      <name>Seob Jeon</name>
    </author>
    <author>
      <name>Ki Hyung Kim</name>
    </author>
    <author>
      <name>Hyeong In Ha</name>
    </author>
    <author>
      <name>Youngbok Ko</name>
    </author>
    <author>
      <name>SanHui Lee</name>
    </author>
    <author>
      <name>Suk-Joon Chang</name>
    </author>
    <author>
      <name>Sang-Yoon Park</name>
    </author>
    <author>
      <name>Myong Cheol Lim</name>
    </author>
    <id>http://schca-ir.schmc.ac.kr/handle/2022.oak/4713</id>
    <updated>2024-09-27T07:02:09Z</updated>
    <published>2022-12-31T15:00:00Z</published>
    <summary type="text">Title: A randomized, multicenter, open-label phase III trial of hyperthermic intraperitoneal chemotherapy in platinum-resistant recurrent ovarian cancer
All Author(s): Ji Hyun Kim; Eun-Young Park; Dae Hoon Jeong; Yoo Young Lee; Chel Hun Choi; Tae-Joong Kim; Hyun Hoon Chung; Taek Sang Lee; Shin Wha Lee; Jeong-Yeol Park; Sung Jong Lee; Seob Jeon; Ki Hyung Kim; Hyeong In Ha; Youngbok Ko; SanHui Lee; Suk-Joon Chang; Sang-Yoon Park; Myong Cheol Lim</summary>
    <dc:date>2022-12-31T15:00:00Z</dc:date>
  </entry>
  <entry>
    <title>EP21.38: Atypical presentation of invasive mole in a perimenopausal woman</title>
    <link rel="alternate" href="http://schca-ir.schmc.ac.kr/handle/2022.oak/4720" />
    <author>
      <name>Y. Kim</name>
    </author>
    <id>http://schca-ir.schmc.ac.kr/handle/2022.oak/4720</id>
    <updated>2024-09-27T07:02:09Z</updated>
    <published>2023-12-31T15:00:00Z</published>
    <summary type="text">Title: EP21.38: Atypical presentation of invasive mole in a perimenopausal woman
All Author(s): Y. Kim</summary>
    <dc:date>2023-12-31T15:00:00Z</dc:date>
  </entry>
  <entry>
    <title>A randomized, multicenter, open-label phase III trial of hyperthermic intraperitoneal chemotherapy in platinum-resistant recurrent ovarian cancer (KOV-HIPEC-02)</title>
    <link rel="alternate" href="http://schca-ir.schmc.ac.kr/handle/2022.oak/4687" />
    <author>
      <name>Myong Cheol Lim</name>
    </author>
    <author>
      <name>Ji Hyun Kim</name>
    </author>
    <author>
      <name>Eun Young Park</name>
    </author>
    <author>
      <name>Dae Hoon Jeong</name>
    </author>
    <author>
      <name>Yoo-Young Lee</name>
    </author>
    <author>
      <name>Chel Hun Choi</name>
    </author>
    <author>
      <name>Sungjong Lee</name>
    </author>
    <author>
      <name>Shin-Wha Lee</name>
    </author>
    <author>
      <name>Jeong-Yeol Park</name>
    </author>
    <author>
      <name>Se Ik Kim</name>
    </author>
    <author>
      <name>Jong Chul Baek</name>
    </author>
    <author>
      <name>Hyeong In Ha</name>
    </author>
    <author>
      <name>Yong Jung Song</name>
    </author>
    <author>
      <name>Seob Jeon</name>
    </author>
    <author>
      <name>Taek Sang Lee</name>
    </author>
    <author>
      <name>Hye won Jeon</name>
    </author>
    <author>
      <name>Ki Hyung Kim</name>
    </author>
    <author>
      <name>Sang-Yoon Park</name>
    </author>
    <id>http://schca-ir.schmc.ac.kr/handle/2022.oak/4687</id>
    <updated>2024-08-28T07:07:25Z</updated>
    <published>2023-12-31T15:00:00Z</published>
    <summary type="text">Title: A randomized, multicenter, open-label phase III trial of hyperthermic intraperitoneal chemotherapy in platinum-resistant recurrent ovarian cancer (KOV-HIPEC-02)
All Author(s): Myong Cheol Lim; Ji Hyun Kim; Eun Young Park; Dae Hoon Jeong; Yoo-Young Lee; Chel Hun Choi; Sungjong Lee; Shin-Wha Lee; Jeong-Yeol Park; Se Ik Kim; Jong Chul Baek; Hyeong In Ha; Yong Jung Song; Seob Jeon; Taek Sang Lee; Hye won Jeon; Ki Hyung Kim; Sang-Yoon Park</summary>
    <dc:date>2023-12-31T15:00:00Z</dc:date>
  </entry>
</feed>

